These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 27624652)

  • 41. The long non-coding RNA Neat1 is an important mediator of the therapeutic effect of bexarotene on traumatic brain injury in mice.
    Zhong J; Jiang L; Huang Z; Zhang H; Cheng C; Liu H; He J; Wu J; Darwazeh R; Wu Y; Sun X
    Brain Behav Immun; 2017 Oct; 65():183-194. PubMed ID: 28483659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 43. siRNA Blocking of Mammalian Target of Rapamycin (mTOR) Attenuates Pathology in Annonacin-Induced Tauopathy in Mice.
    Salama M; El-Desouky S; Alsayed A; El-Hussiny M; Magdy K; Fekry E; Shabka O; El-Khodery SA; Youssef MA; Sobh M; Mohamed W
    Neurotox Res; 2019 May; 35(4):987-992. PubMed ID: 30362086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bexarotene Does Not Clear Amyloid Beta Plaques but Delays Fibril Growth: Molecular Mechanisms.
    Huy PDQ; Thai NQ; Bednarikova Z; Phuc LH; Linh HQ; Gazova Z; Li MS
    ACS Chem Neurosci; 2017 Sep; 8(9):1960-1969. PubMed ID: 28689412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevention of lung cancer progression by bexarotene in mouse models.
    Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
    Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dietary Lycopene Supplementation Improves Cognitive Performances in Tau Transgenic Mice Expressing P301L Mutation via Inhibiting Oxidative Stress and Tau Hyperphosphorylation.
    Yu L; Wang W; Pang W; Xiao Z; Jiang Y; Hong Y
    J Alzheimers Dis; 2017; 57(2):475-482. PubMed ID: 28269786
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Possible Molecular Interactions of Bexarotene - A Retinoid Drug and Alzheimer's Aβ Peptide: A Docking Study.
    Mirza Z; Beg MA
    Curr Alzheimer Res; 2017; 14(3):327-334. PubMed ID: 27842487
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Breviscapine confers a neuroprotective efficacy against transient focal cerebral ischemia by attenuating neuronal and astrocytic autophagy in the penumbra.
    Pengyue Z; Tao G; Hongyun H; Liqiang Y; Yihao D
    Biomed Pharmacother; 2017 Jun; 90():69-76. PubMed ID: 28343073
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: possible implication for neurodegenerative diseases.
    Menuet C; Borghgraef P; Voituron N; Gestreau C; Gielis L; Devijver H; Dutschmann M; Van Leuven F; Hilaire G
    Neurobiol Dis; 2012 Apr; 46(1):234-43. PubMed ID: 22316605
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adaptive responses to alloxan-induced mild oxidative stress ameliorate certain tauopathy phenotypes.
    Yoshiike Y; Yamashita S; Mizoroki T; Maeda S; Murayama M; Kimura T; Sahara N; Soeda Y; Takashima A
    Aging Cell; 2012 Feb; 11(1):51-62. PubMed ID: 21981382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tau oligomers as potential targets for early diagnosis of tauopathy.
    Sahara N; Ren Y; Ward S; Binder LI; Suhara T; Higuchi M
    J Alzheimers Dis; 2014; 40 Suppl 1():S91-6. PubMed ID: 24595194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poloxamer 188 Attenuates Cerebral Hypoxia/Ischemia Injury in Parallel with Preventing Mitochondrial Membrane Permeabilization and Autophagic Activation.
    Luo C; Li Q; Gao Y; Shen X; Ma L; Wu Q; Wang Z; Zhang M; Zhao Z; Chen X; Tao L
    J Mol Neurosci; 2015 Aug; 56(4):988-998. PubMed ID: 25966641
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of support for bexarotene as a treatment for Alzheimer's disease.
    O'Hare E; Jeggo R; Kim EM; Barbour B; Walczak JS; Palmer P; Lyons T; Page D; Hanna D; Meara JR; Spanswick D; Guo JP; McGeer EG; McGeer PL; Hobson P
    Neuropharmacology; 2016 Jan; 100():124-30. PubMed ID: 26025659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Filamentous tau in oligodendrocytes and astrocytes of transgenic mice expressing the human tau isoform with the P301L mutation.
    Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
    Am J Pathol; 2003 Jan; 162(1):213-8. PubMed ID: 12507904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fingolimod suppresses neuronal autophagy through the mTOR/p70S6K pathway and alleviates ischemic brain damage in mice.
    Li X; Wang MH; Qin C; Fan WH; Tian DS; Liu JL
    PLoS One; 2017; 12(11):e0188748. PubMed ID: 29186197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.
    Casarejos MJ; Perucho J; Gomez A; Muñoz MP; Fernandez-Estevez M; Sagredo O; Fernandez Ruiz J; Guzman M; de Yebenes JG; Mena MA
    J Alzheimers Dis; 2013; 35(3):525-39. PubMed ID: 23478312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein.
    de Vries-van der Weij J; de Haan W; Hu L; Kuif M; Oei HL; van der Hoorn JW; Havekes LM; Princen HM; Romijn JA; Smit JW; Rensen PC
    Endocrinology; 2009 May; 150(5):2368-75. PubMed ID: 19147676
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo.
    Violet M; Chauderlier A; Delattre L; Tardivel M; Chouala MS; Sultan A; Marciniak E; Humez S; Binder L; Kayed R; Lefebvre B; Bonnefoy E; Buée L; Galas MC
    Neurobiol Dis; 2015 Oct; 82():540-551. PubMed ID: 26385829
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis.
    Lastres-Becker I; Innamorato NG; Jaworski T; Rábano A; Kügler S; Van Leuven F; Cuadrado A
    Brain; 2014 Jan; 137(Pt 1):78-91. PubMed ID: 24277722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.